Compare ABVE & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABVE | NEPH |
|---|---|---|
| Founded | 2019 | 1997 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.3M | 37.7M |
| IPO Year | N/A | 2004 |
| Metric | ABVE | NEPH |
|---|---|---|
| Price | $0.58 | $3.65 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | ★ 4.5M | 32.6K |
| Earning Date | 07-09-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1000.00 |
| EPS | N/A | ★ 0.01 |
| Revenue | N/A | ★ $18,789,000.00 |
| Revenue This Year | N/A | $11.24 |
| Revenue Next Year | N/A | $11.58 |
| P/E Ratio | ★ N/A | $369.50 |
| Revenue Growth | N/A | ★ 32.67 |
| 52 Week Low | $0.32 | $2.66 |
| 52 Week High | $6.56 | $6.42 |
| Indicator | ABVE | NEPH |
|---|---|---|
| Relative Strength Index (RSI) | 47.28 | 57.72 |
| Support Level | $0.43 | $3.64 |
| Resistance Level | $1.07 | $3.78 |
| Average True Range (ATR) | 0.08 | 0.28 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 60.59 | 85.23 |
Above Food Ingredients Inc is a differentiated, regenerative ingredient company. Its products are made with real nutritious, flavorful ingredients and delivered with transparency. Its vision is to create a healthier world one seed, one field, and one bite at a time. With a robust chain of custody of plant proteins, enabled by scaled operations and infrastructure in primary agriculture and processing, and proprietary seed development capabilities that leverage the power of artificial intelligence driven genomics. The company delivers nutritious foods to businesses and consumers with traceability and sustainability. Above Food's consumer products and brands are available in grocers across Canada and the United States.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.